NHS

Oncology

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

News

Hundreds of women with locally advanced cervical cancer are to be offered MSD's Keytruda on the NHS in England, thanks to new NICE guidance.

News

New NICE guidance means that around 90 UK women with cervical cancer should be eligible for treatment with Regeneron's Libtayo each year.

News

People with early type 1 diabetes in England and Wales will soon be able to access Sanofi's Tzield, which can delay the need for insulin injections.

R&D

We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.

News

A study linking dispensing data to patient characteristics in England has exposed differences in medicine use across ethnic and socioeconomic groups.